CoChat

Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)

Open access
Rauch, Jennifer N., Chen, John J., Sorum, Alexander W., Miller, Gregory M., Sharf, Tal, See, Stephanie K., Hsieh-Wilson, Linda C., Kampmann, Martin, Kosik, Kenneth S. · 2018 · Scientific Reports

Published version of a preprint

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; 4 of the 21 sources its claims cite were checked for support.

Abstract

The misfolding and accumulation of tau protein into intracellular aggregates known as neurofibrillary tangles is a pathological hallmark of neurodegenerative diseases such as Alzheimer’s disease. However, while tau propagation is a known marker for disease progression, exactly how tau propagates from one cell to another and what mechanisms govern this spread are still unclear. Here, we report that cellular internalization of tau is regulated by quaternary structure and have developed a cellular assay to screen for genetic modulators of tau uptake. Using CRISPRi technology we have tested 3200 genes for their ability to regulate tau entry and identified enzymes in the heparan sulfate proteoglycan biosynthetic pathway as key regulators. We show that 6- O -sulfation is critical for tau-heparan sulfate interactions and that this modification regulates uptake in human central nervous system cell lines, iPS-derived neurons, and mouse brain slice culture. Together, these results suggest novel strategies to halt tau transmission.

Overview

CoChat Summary

TL;DR

Tau internalization is regulated by quaternary structure, with monomer, oligomer, and sonicated fibrils taken up efficiently while intact fibrils are not. A CRISPRi screen identified heparan sulfate proteoglycan biosynthetic enzymes, and 6-O-sulfation on heparan sulfate was critical for tau binding and uptake across CNS cell lines, iPS-derived neurons, and mouse brain slice culture.

Key findings

  • Tau uptake depended on size/quaternary structure: DLS showed monomer at 5.7 ± 0.9 nm, oligomers at 19 ± 3 nm, sonicated fibrils at 33 ± 11 nm, and fibrils at 80 ± 8 nm; H4 cells and iPS-derived neurons internalized monomer, oligomer, and sonicated fibrils efficiently, but fibrils showed nearly no uptake.
  • A CRISPRi screen of 3200 genes with five sgRNAs per gene identified HSPG biosynthesis genes EXT2 and HS6ST1 and endocytosis gene DNM2; single knockdowns repressed tau monomer uptake by over 50%, also reduced oligomer uptake, and reduced tau uptake in iPS-derived neurons.
  • Heparin ELISA showed tau bound heparin with affinity 4.6 ± 0.6 nM, oversulfated heparin at 2.2 ± 0.5 nM, fully desulfated heparin >1 μM, N-desulfated heparin 15.0 ± 5 nM, 2-O-desulfated heparin 7.4 ± 1.0 nM, and 6-O-desulfated heparin >1 μM; relative binding of 6-O-desulfated heparin at 10 nM tau was 6.9% that of heparin.
  • Competition with soluble heparin derivatives reduced tau uptake in H4 cells, iPS-derived neurons, and mouse slice culture; 6-O-desulfated heparin and chondroitin sulfate were less effective. Overexpression of Sulf1 reduced uptake to 17 ± 9% and Sulf2 to 36 ± 15%.

Methods

  • Recombinant full-length 2N4R tau was purified, labeled with AF488 or AF647, and prepared as monomer, oligomer, sonicated fibril, or fibril using heparin; constructs were characterized by non-reducing SDS-PAGE, TEM, and DLS. Uptake was measured by flow cytometry in H4, SHSY-5Y, ReN VM, and iPS-derived neurons, with 4 °C controls subtracted, and by imaging in mouse brain slice culture.
  • For the CRISPRi screen, H4 cells expressing dCas9-KRAB were transduced with a next-generation sgRNA library targeting 3200 genes with five sgRNAs per gene plus non-targeting controls, incubated with 25 nM AF488-labeled 2N4R monomer for 1 h, sorted into top and bottom thirds of fluorescence, and sgRNA abundance was determined by next-generation sequencing; significance was calculated using the Mann-Whitney U test against 280 non-targeting sgRNAs.
  • Binding and validation used a heparin ELISA with biotinylated heparin derivatives and myc-tagged 2N4R, Hill binding model fitting, cellular competition with soluble heparin derivatives, Sulf1/Sulf2 overexpression, qPCR, immunocytochemistry, and HPLC disaccharide analysis.

Limitations

  • The paper states that this work focused only on uptake of “naked” tau and did not address seeding potential or possible exosome transfer of fibrils between neurons; it also states that further work is needed to understand whether specific HS chain lengths or regions on tau are important for the interaction.
  • The paper states that further work will be needed to dissect if and how cell cycle regulator hits influence post-mitotic neurons.
  • Evident from the text: the primary CRISPRi screen used monomeric tau in an H4 cell line, so the screen may not capture all regulators of oligomer or fibril uptake; validation was limited to selected genes, and the ex vivo mouse slice data rely on imaging/median fluorescence rather than mechanistic dissection.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41598-018-24904-z

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Tau uptake is regulated by quaternary structure. (a) 2N4R monomer, oligomer, and fibrillized proteins show distinct banding patterns on a non-reducing SDS-PAGE gel. 2N4R Fibrils before (top) and after (bottom) sonication as visualized by negative-stain EM. Bar represents 500 nm (b) DLS of 2N4R monomer, oligomer, fibril, and sonicated fibril species. Experiments were performed in triplicate and the error shown is SD. (c) Uptake of 2N4R quaternary structures in H4 cells after 1 h at 37 °C. (d) Uptake of 2N4R quaternary structures in iPS-derived neurons after 1 h at 37 °C. For all uptake experiments, three independent experiments were performed in duplicate, identical control experiments were performed at 4 °C and subtracted from 37 °C data to generate final curves shown, and the error shown is SEM.
Figure 1 Tau uptake is regulated by quaternary structure. (a) 2N4R monomer, oligomer, and fibrillized proteins show distinct banding patterns on a non-reducing SDS-PAGE gel. 2N4R Fibrils before (top) and after (bottom) sonication as visualized by negative-stain EM. Bar represents 500 nm (b) DLS of 2N4R monomer, oligomer, fibril, and sonicated fibril species. Experiments were performed in triplicate and the error shown is SD. (c) Uptake of 2N4R quaternary structures in H4 cells after 1 h at 37 °C. (d) Uptake of 2N4R quaternary structures in iPS-derived neurons after 1 h at 37 °C. For all uptake experiments, three independent experiments were performed in duplicate, identical control experiments were performed at 4 °C and subtracted from 37 °C data to generate final curves shown, and the error shown is SEM.CC BY · PubMed Central
Figure 2 CRISPRi screen for tau uptake modulators. (a) Screening strategy using H4 CRISPRi cells, see text for details. (b) Reconfirmation of selected hits in H4i cells with 2N4R monomer (50 nM, 1 h at 37 °C), normalized to a WT (no sgRNA) control. (c) Uptake of 2N4R oligomers (50 nM, 1 h at 37 °C) in H4i cells with selected gene knockdowns, normalized to a WT (no sgRNA) control. (d) Uptake of 2N4R monomer (200 nM, 1 h at 37 °C) in iPS-derived neurons with selected gene knockdowns, normalized to a WT (no sgRNA) control. All uptake experiments were performed in duplicate over three independent experiments with the data combined. Lines on the graphs represent WT mean +/− 3 standard deviations, error bars represent SEM, a one-way ANOVA analysis with Dunnett’s method was used to determine significance between the gene knockdown and the non-targeting sgRNA *p-value ≤ 0.05, **p-value ≤ 0.01, ***p-value ≤ 0.001.
Figure 2 CRISPRi screen for tau uptake modulators. (a) Screening strategy using H4 CRISPRi cells, see text for details. (b) Reconfirmation of selected hits in H4i cells with 2N4R monomer (50 nM, 1 h at 37 °C), normalized to a WT (no sgRNA) control. (c) Uptake of 2N4R oligomers (50 nM, 1 h at 37 °C) in H4i cells with selected gene knockdowns, normalized to a WT (no sgRNA) control. (d) Uptake of 2N4R monomer (200 nM, 1 h at 37 °C) in iPS-derived neurons with selected gene knockdowns, normalized to a WT (no sgRNA) control. All uptake experiments were performed in duplicate over three independent experiments with the data combined. Lines on the graphs represent WT mean +/− 3 standard deviations, error bars represent SEM, a one-way ANOVA analysis with Dunnett’s method was used to determine significance between the gene knockdown and the non-targeting sgRNA *p-value ≤ 0.05, **p-value ≤ 0.01, ***p-value ≤ 0.001.CC BY · PubMed Central
Figure 3 Binding of tau to heparin derivatives. (a) HS chains consist of GlcA/IdoA-GlcNAc disaccharide units that can be modified at positions indicated in red and blue. (b) List of heparin/heparin derivatives that were used, their average molecular weights, and description of their sulfation modifications. (c) Binding of 2N4R to various heparin derivatives by ELISA with data fit to a Hill binding model (line) where appropriate. (d) Normalized relative binding of 2N4R (10 nM) to various heparin derivatives. Three independent experiments were performed, data were normalized to heparin controls, and the error shown is SD.
Figure 3 Binding of tau to heparin derivatives. (a) HS chains consist of GlcA/IdoA-GlcNAc disaccharide units that can be modified at positions indicated in red and blue. (b) List of heparin/heparin derivatives that were used, their average molecular weights, and description of their sulfation modifications. (c) Binding of 2N4R to various heparin derivatives by ELISA with data fit to a Hill binding model (line) where appropriate. (d) Normalized relative binding of 2N4R (10 nM) to various heparin derivatives. Three independent experiments were performed, data were normalized to heparin controls, and the error shown is SD.CC BY · PubMed Central
Figure 4 6-O sulfation regulates tau uptake in CNS culture. (a) Internalization of 2N4R-488 (50 nM, 1 h at 37 °C) into H4 cells is strongly inhibited by incubation with heparin, heparan sulfate, and 2-O-desulfated heparin as compared to 6-O-desulfated heparin or chondroitin sulfate (0.05 mg/ml for all derivatives). (b) Internalization of 2N4R-488 (200 nM, 1 h at 37 °C) into iPS-derived neurons is inhibited by incubation with heparin, heparan sulfate, and 2-O-desulfated heparin as compared to 6-O-desulfated heparin or chondroitin sulfate (0.5 mg/ml for all derivatives). All uptake experiments were performed in duplicate over three independent experiments with the data combined. Lines on the graphs represent WT mean +/− 3 standard deviations, error bars represent SEM, and a one-way ANOVA analysis with Dunnett’s method was used to determine significance compared to the negative control *p-value ≤ 0.05, **p-value ≤ 0.01, ***p-value ≤ 0.001, ns = not significant. (c) Internalization of 2N4R-488 (200 nM, 30 min at 37 °C) into mouse slice culture is strongly inhibited by incubation with 2-O-desulfated heparin, but not 6-O-desulfated heparin (0.5 mg/ml). Hoechst stain is used to label nuclei. (d) Quantification of the median 488 fluorescence intensity for tau uptake in mouse slice culture. Two independent experiments were performed with multiple images (>5) from each condition. Error bars represent SEM. (e) Uptake of 2N4R-488 (50 nM, 1 h at 37 °C) tau is reduced when Sulf1 or Sulf2 is overexpressed in H4 cells as compared to WT or mock transfected cells. Uptake experiments were performed in duplicate over three independent experiments with the data normalized to WT and combined. Error bars represent SEM. (f) ICC confirms that Sulf1 and Sulf2 are overexpressed (red) in H4 cells. Hoechst stain is used to label nuclei.
Figure 4 6-O sulfation regulates tau uptake in CNS culture. (a) Internalization of 2N4R-488 (50 nM, 1 h at 37 °C) into H4 cells is strongly inhibited by incubation with heparin, heparan sulfate, and 2-O-desulfated heparin as compared to 6-O-desulfated heparin or chondroitin sulfate (0.05 mg/ml for all derivatives). (b) Internalization of 2N4R-488 (200 nM, 1 h at 37 °C) into iPS-derived neurons is inhibited by incubation with heparin, heparan sulfate, and 2-O-desulfated heparin as compared to 6-O-desulfated heparin or chondroitin sulfate (0.5 mg/ml for all derivatives). All uptake experiments were performed in duplicate over three independent experiments with the data combined. Lines on the graphs represent WT mean +/− 3 standard deviations, error bars represent SEM, and a one-way ANOVA analysis with Dunnett’s method was used to determine significance compared to the negative control *p-value ≤ 0.05, **p-value ≤ 0.01, ***p-value ≤ 0.001, ns = not significant. (c) Internalization of 2N4R-488 (200 nM, 30 min at 37 °C) into mouse slice culture is strongly inhibited by incubation with 2-O-desulfated heparin, but not 6-O-desulfated heparin (0.5 mg/ml). Hoechst stain is used to label nuclei. (d) Quantification of the median 488 fluorescence intensity for tau uptake in mouse slice culture. Two independent experiments were performed with multiple images (>5) from each condition. Error bars represent SEM. (e) Uptake of 2N4R-488 (50 nM, 1 h at 37 °C) tau is reduced when Sulf1 or Sulf2 is overexpressed in H4 cells as compared to WT or mock transfected cells. Uptake experiments were performed in duplicate over three independent experiments with the data normalized to WT and combined. Error bars represent SEM. (f) ICC confirms that Sulf1 and Sulf2 are overexpressed (red) in H4 cells. Hoechst stain is used to label nuclei.CC BY · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 13 Not checked · 44 Own results and interpretations

16 more claims

Create a free account to see all 60 claims and to verify the 17 references still open.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 20

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 43 references

Cited by

See all 211

Metadata

Authors
Rauch, J. N., Chen, J. J., Sorum, A. W., Miller, G. M., Sharf, T., See, S. K., Hsieh-Wilson, L. C., Kampmann, M., & Kosik, K. S.
Affiliations
  • University of California, Santa Barbara (US)
  • QB3 (US)
  • California Institute of Technology (US)
Corresponding author
Kosik, Kenneth S.
Venue
Scientific Reports
Published
2018-04-23
Volume
8
Issue
1
Pages
6382-6382
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2950870451
Cited by
211
References
42
Citations by year
2026: 20 · 2025: 28 · 2024: 13 · 2023: 21 · 2022: 20 · 2021: 39 · 2020: 38 · 2019: 23 · 2018: 9
FWCI
18.68
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • Alzheimer's Association
  • National Institutes of Health (NS100717)
  • University of California, Santa Barbara
  • University of California, San Francisco
  • National Defense Science and Engineering Graduate
  • Tau Consortium
  • National Institute of General Medical Sciences (T32GM007616, GM007616, T32GM064337, DP2GM119139, R01GM093627, GM119139)
  • National Institute of Neurological Disorders and Stroke (U54NS100717, NS100717)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Keywords
tau protein, heparan sulfate proteoglycans, 6-O-sulfation, tau propagation, neurofibrillary tangles, Alzheimer's disease, CRISPRi screen, heparan sulfate biosynthesis, iPSC-derived neurons, brain slice culture
MeSH terms
Exostosin 2, Animals, Brain, Glioma, Humans, Sulfur, Tumor Cells, Cultured, Sulfotransferases, tau Proteins, N-Acetylglucosaminyltransferases, Heparan Sulfate Proteoglycans, Protein Structure, Quaternary, Genomics, Dynamin II, Mice, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs). https://app.cochat.ai/papers/10.1038/s41598-018-24904-z
The paper
Rauch, J. N., Chen, J. J., Sorum, A. W., Miller, G. M., Sharf, T., See, S. K., Hsieh-Wilson, L. C., Kampmann, M., & Kosik, K. S. (2018). Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs). Scientific Reports. https://doi.org/10.1038/s41598-018-24904-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.